Summary
Wells Fargo & Company/MN (WFC) filed its quarterly report for the period ending September 29, 2025. The report details significant share repurchase activity during the quarter and provides updates on legal proceedings and risk factors, which are incorporated by reference. Notably, the company issued 411,536 shares of common stock to plaintiffs' counsel as part of a settlement for a shareholder derivative action, utilizing an exemption from registration. This issuance is a key event to consider alongside the ongoing share repurchase program, which continued at a substantial pace throughout the quarter. Investors should note the significant volume of share repurchases, totaling over 74.5 million shares for the quarter, indicating the company's commitment to returning capital to shareholders. The use of a registration exemption for the settlement shares suggests a resolution to a specific legal matter. While detailed financial performance metrics are not within this excerpt, the information on equity transactions and legal updates provides crucial context for understanding the company's capital management and its approach to resolving legal challenges.
Financial Highlights
33 data points| Net Income | $5.59B |
| EPS (Basic) | $1.68 |
| EPS (Diluted) | $1.66 |
| Shares Outstanding (Basic) | 3.18B |
| Shares Outstanding (Diluted) | 3.22B |
Key Highlights
- 1Issued 411,536 shares of common stock to plaintiffs' counsel for the settlement of the Himstreet v. Scharf et al. shareholder derivative action on August 13-14, 2025, under a registration exemption.
- 2Repurchased a total of 74,559,425 shares of common stock during the quarter ended September 30, 2025.
- 3Share repurchases were funded by two Board-approved authorizations: one for up to $30 billion (initiated July 25, 2023) and another for an additional $40 billion (initiated April 29, 2025).
- 4As of September 30, 2025, approximately $34.758 billion remained available under the ongoing share repurchase authorizations.
- 5No directors or officers adopted or terminated Rule 10b5-1 or non-Rule 10b5-1 trading arrangements during the quarter.
- 6Key information regarding Legal Proceedings and Risk Factors is incorporated by reference to other sections of the report (Note 10 and 'Financial Review – Risk Factors').